CLDN18.2

Close
Menu
Books on bookshelves with overlay of abstract gray concentric circles

CLDN18.2 resources

Download additional resources to learn more about how to consistently test, interpret, and report CLDN18.2 in G/GEJ cancer.

CLDN18.2 Reporting Template

Download the guidance from our expert committee.

Global RING Trial Publication

Global Ring Study Determining Reproducibility and Comparability of CLDN18 Testing in Gastric Cancer

IHC Assay Guide

Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.

eLearning Center

Access a self-guided CLDN18.2 educational program.

Visit the eLearning Site

IMAGE

Stay up to date on CLDN18.2

Do you want more information?

 

 

IMAGE

Access to and use of this site is subject to the Terms of use available here. This Site was developed and is maintained by Astellas. Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.

All case reviews and consensus scoring have been independently conducted by the members of the CLDN18.2 Expert Committee. 

©2024 Astellas Pharma, Inc. All rights reserved.

This website is a non-promotional scientific resource, funded and developed by Astellas Pharma a/s.

MAT-NC-NON-2024-00063. Date of preparation: 01.05.2024

Astellas Pharma a/s | Arne Jacobsens Allé 15, DK-2300 Copenhagen S | +45 4343 0355 | kontakt.dk@astellas.com

www.astellas.dk | www.astellas.se | www.astellas.fi | www.astellas.no